Rx Item-Eletriptan 20 Mg Tab 6 By Aurobindo Pharma Ltd USA G

Rx Item-Eletriptan 20 Mg Tab 6 By Aurobindo Pharma Ltd USA Gen Relpax

Item No. RX700700, 700700, Ndc# 59651-0104-69 59651-104-69 5965110469 59651010469 Upc Code: 3-59651-10469-9 359651-104699 359651104699 Eletriptan 20 Mg Tab 6 By Aurobindo Pharma Ltd U.S Only Physician,Pharmacy Or Licensed Facility Can Order This RX

Part Number: RX700700

Feature: Drug Class: Drug Class: 28322800 Selective Serotonin Agonists

Feature: OMP Family: Waiting for Details

Feature: Temparature Zone: 10 Room Temperature

Feature: Unit Dose Indicator: UD

Feature 5 Item Size: 6

You need to be a registered customer to order this product. Please Login to your account or click here to Register.

The item you are trying to purchase is currently out of stock.
Please enter your name, email, and phone number below.
We will contact you as soon as this product is available.

Name: *

Email: *

Phone: *

Verification: *

Type the word above...

Description
Feature 6
Feature 7
Feature 8
Feature 9
Feature 10
Feature 11
Feature 12
Feature 13

Clinical Information

Gen. Code and Des.

65944 cream base no.32 MISCELL CREAM (G)

GCN and Des.

28082 cream base no.32 MISCELL CREAM (G)

Strength

Dose Form

CREAM (GRAM)

Product Category

OT Over the Counter

Fine Line Class

790079407948 Miscellaneous Compounding Supplies

DEA Class

OMP Family

AHFS Class

96000000 PHARMACEUTICAL AIDS

Active Ingredients

13346 cream base no.32

These highlights do not include all the information needed to use ELETRIPTAN HYDROBROMIDE TABLETS safely and effectively. See full prescribing information for ELETRIPTAN HYDROBROMIDE TABLETS.

ELETRIPTAN HYDROBROMIDE tablets, for oral use

Initial U.S. Approval: 2002

INDICATIONS AND USAGE

Eletriptan hydrobromide is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults (1)

Limitations of Use:

Use only after a clear diagnosis of migraine has been established (1)

Not indicated for the prophylactic therapy of migraine (1)

Not indicated for the treatment of cluster headache (1)

DOSAGE AND ADMINISTRATION

Single dose: 20 mg or 40 mg (2)

Maximum single dose: 40 mg (2)

May repeat dose after 2 hours if needed; not to exceed 80 mg in any 24-hour period (2)

DOSAGE FORMS AND STRENGTHS

Tablets: 20 mg and 40 mg (3)

CONTRAINDICATIONS

History of coronary artery disease (CAD) or coronary artery vasospasm (4)

Wolff-Parkinson-White syndrome or other cardiac accessory conduction pathway disorders (4)

History of stroke, transient ischemic attack, or history or current evidence of hemiplegic or basilar migraine (4)

Peripheral vascular disease (4)

Ischemic bowel disease (4)

Uncontrolled hypertension (4)

Within 24 hours of treatment with another 5-HT1 agonist, or an ergotamine-containing medication (4)

Hypersensitivity to eletriptan hydrobromide tablets (angioedema and anaphylaxis seen) (4)

Within at least 72 hours of treatment with the following potent CYP3A4 inhibitors: ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, or nelfinavir (4)

WARNINGS AND PRECAUTIONS

Myocardial ischemia/infarction or Prinzmetal’s angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors (5.1)

Arrhythmias: Discontinue eletriptan hydrobromide if occurs (5.2)

Chest/throat/neck/jaw pain, tightness, pressure, or heaviness: Generally not myocardial ischemia; evaluate high risk patients for CAD (5.3)

Cerebral hemorrhage, subarachnoid hemorrhage, or stroke: Discontinue eletriptan hydrobromide if occurs (5.4)

Gastrointestinal ischemia or infarction events, or peripheral vasospastic reactions: Discontinue eletriptan hydrobromide if occurs (5.5)

Medication overuse headache: Detoxification may be necessary (5.6)

Serotonin syndrome: Discontinue eletriptan hydrobromide if occurs (5.7, 7.3)

ADVERSE REACTIONS

Most common adverse reactions (= 5% and >placebo) were asthenia, nausea, dizziness, and somnolence. These reactions appear to be dose-related. (6.1)

To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

USE IN SPECIFIC POPULATIONS

Pregnancy: Based on animal data, may cause fetal harm (8.1)

See 17 for PATIENT COUNSELING INFORMATION.

Revised: 4/2020

Rx Item-Eletriptan 20 Mg Tab 6 By Aurobindo Pharma Ltd USA Gen Relpax

Recently Viewed Items